Abstract Details
9/09/2025 | 2:15 PM - 3:15 PM | Breakout 6 | Thomas H. Swain
Evaluating the Impact of Universal Newborn cCMV Screening on Newborn Hearing Screening and Follow-up
Abstract Summary
Congenital Cytomegalovirus (cCMV) is a prevalent congenital infection and the most common cause of non-genetic permanent hearing loss in children, making early identification and intervention important for better outcomes. In 2023, Minnesota (MN) became the first U.S. state to implement universal newborn screening for CMV. Infants are screened using dried blood spots, with a confirmatory urine test recommended within the first 21 days of life if cytomegalovirus (CMV) is detected. To ensure optimal outcomes, infants diagnosed with cCMV infection will need more frequent audiologic monitoring to detect emerging hearing loss or vestibular dysfunction, identify progression of existing hearing loss, and plan appropriate intervention. MN Department of Health (MDH) audiology guidelines for infants with cCMV recommend an initial diagnostic audiology assessment by 1 month of age or within 1 month of the confirmatory urine test, a second diagnostic audiology assessment between 4 to 5 months of age, and ongoing audiology evaluations until the child reaches 10 years of age. During the first two years of screening, 120,040 infants were screened for cCMV, resulting in an observed prevalence rate of 0.3% among Minnesota live births. This presentation will discuss the results of newborn hearing screens, diagnostic audiology assessments, and the timeliness of audiology follow-up procedures. Longitudinal follow-up for cCMV-positive infants diagnosed with a hearing loss, including multi-disciplinary partnerships, referrals to Early Intervention programs and parent support, will be outlined. The presentation will also summarize key indicators evaluated by the MDH over time and the outcomes observed among infants diagnosed with cCMV with hearing loss. This information highlights the importance of these efforts in connecting families to support services and promoting healthy development for affected infants.
Learning Objectives
- Describe the approach to universal screening for CMV and audiology monitoring for infants/children with cCMV implemented in Minnesota.
- Describe longitudinal follow-up of cCMV-positive infants diagnosed with a hearing loss.
- Summarize future considerations for fine tuning guidelines and follow-up practices.
Presentation
This presentation has not yet been uploaded.
Handouts
No handouts have been uploaded.
Presenters
Sara Lammert | Primary Presenter, Co-Author
sara.lammert@state.mn.us;
Sara Lammert is an epidemiologist in the Longitudinal Follow-up unit at the Minnesota Department of Health (MDH) focusing on hearing loss and critical congenital heart disease. Sara received her Bachelor of Arts in biology from the College of the Holy Cross, her Master of Public Health in epidemiology and biostatistics from the Boston University School of Public Health, and her PhD in epidemiology from the University of Minnesota.
ASHA DISCLOSURE
Financial - No relevant financial relationship exists.
Nonfinancial - No relevant nonfinancial relationship exists.
AAA DISCLOSURE
Financial - No relevant financial relationship exists.
Amanda Pavan | Co-Presenter, Co-Author
amanda.pavan@state.mn.us;
Amanda is an Epidemiologist with the Minnesota Department of Health’s Newborn Screening Program. Amanda has a Ph.D. in medical geography with expertise in epidemiology, spatial analysis, maternal-child health, and environmental health.
ASHA DISCLOSURE
Financial -
Nonfinancial -
AAA DISCLOSURE
Financial - No relevant financial relationship exists.
Lexie Barber | Co-Author
lexie.barber@state.mn.us;
Lexie Barber is an epidemiologist in the Longitudinal Follow-up unit at the Minnesota Department of Health (MDH) focusing on congenital CMV and heritable conditions. Lexie joined the team in December 2022. Previously, she worked in the infectious disease divisions at MDH and the North Dakota Department of Health working mainly in vaccine preventable diseases. Lexie received her Bachelor of Science in microbiology at North Dakota State University and her Master of Public Health in environmental health from the University of Minnesota.
ASHA DISCLOSURE
Financial - No relevant financial relationship exists.
Nonfinancial - No relevant nonfinancial relationship exists.
AAA DISCLOSURE
Financial - No relevant financial relationship exists.
Kirsten Coverstone | Co-Author
kirsten.coverstone@state.mn.us;
Dr. Kirsten Coverstone is an audiologist at the Minnesota Department of Health (MDH) Newborn Screening Program. As a coordinator of Minnesota’s EHDI program, Kirsten has worked at the local, state, and national levels to support best practice for universal newborn screening, timely & complete audiologic follow-up for hearing, and early access to intervention. In addition, Kirsten implemented the statewide hearing instrument loaner program for infants and young children in Minnesota. Universal screening, education, and follow-up for congenital cytomegalovirus (cCMV) has been a longstanding aspiration as cCMV is the leading cause of non-genetic hearing loss and is intricately related to EHDI. She has served as Co-Chair of the Joint Committee on Infant Hearing (JCIH), & Co-Chair of the Center for Disease Control (CDC) EHDI Data Committee.
ASHA DISCLOSURE
Financial -
Nonfinancial -
AAA DISCLOSURE
Financial - No relevant financial relationship exists.
Darcia Dierking | Co-Author
darcia.dierking@state.mn.us;
Darcia Dierking is a pediatric audiologist and MDH EHDI Co-Coordinator. Darcia has more than 20 years of experience as a clinical and research audiologist, with research projects primarily focusing on otoacoustic emissions and hearing devices. Darcia has worked in four states and has experience teaching hospital staff and Early Head Start staff about hearing screening. As a part of the MDH EHDI program, she works in longitudinal follow-up after identification. She works with many grant recipients and stakeholders in government, healthcare, education and family organizations to make EHDI system improvements.
ASHA DISCLOSURE
Financial -
Nonfinancial -
AAA DISCLOSURE
Financial - No relevant financial relationship exists.
Gina Liverseed | Co-Author
gina.liverseed@state.mn.us;
Gina Liverseed is the CMV Nurse Specialist in the Children and Youth with Special Health Needs section at the Minnesota Department of Health. In this role, she is responsible for coordinating the longitudinal follow-up of children identified with congenital CMV and providing education about CMV to public and provider audiences. She holds Bachelor and Master of Nursing degrees from the University Minnesota and a Doctor of Nursing Practice degree from the University of North Dakota. Gina has over 20 years of experience working as a maternal-child health nurse and a Women’s Health Nurse Practitioner. She has a special interest in perinatal infectious disease.
ASHA DISCLOSURE
Financial - No relevant financial relationship exists.
Nonfinancial - No relevant nonfinancial relationship exists.
AAA DISCLOSURE
Financial - No relevant financial relationship exists.
Annikka Strong | Co-Author
annikka.strong@state.mn.us;
Annikka works with the Minnesota Department of Health, Newborn Screening Program, Point of Care team. She provides follow-up for Minnesota babies' inpatient newborn screening results and audiology journey.
She also coordinates follow-up on lost to follow-up cases sent to Local Public Health contacts and leads audiologic follow-up for confirmed congenital CMV cases.
ASHA DISCLOSURE
Financial -
Nonfinancial -
AAA DISCLOSURE
Financial - No relevant financial relationship exists.
Melanie Wege | Co-Author
melanie.wege@state.mn.us;
Melanie Wege is a board certified audiologist who joined the Minnesota EHDI Team after 17 years as a clinical audiologist with a primary interest in pediatric diagnosis and follow-up. Her focus with the Minnesota EHDI Team is to provide education, support, and ongoing quality system improvement strategies to all providers involved with infant hearing screening and follow-up.
ASHA DISCLOSURE
Financial -
Nonfinancial -
AAA DISCLOSURE
Financial - No relevant financial relationship exists.